Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Kanishk Kumar: TFPI Market Size – Advancing Hemostasis and Antithrombotic Therapy
Kanishk Kumar/LinkedIn
Oct 2, 2025, 10:48

Kanishk Kumar: TFPI Market Size – Advancing Hemostasis and Antithrombotic Therapy

 

Kanishk Kumar, Digital Marketing Executive at DelveInsight Business Research LLP, posted on LinkedIn:

”Tissue Factor Pathway Inhibitors (TFPI) Market: Advancing Hemostasis and Antithrombotic Therapy

Tissue Factor Pathway Inhibitors (TFPIs) are emerging as a novel class of anticoagulants, offering targeted approaches to manage thrombotic disorders with   potentially improved safety profiles compared to conventional therapies. As cardiovascular and thrombotic disease burdens rise globally, TFPI-based therapies are   gaining attention for their role in precision medicine. Despite challenges like clinical development complexity and regulatory pathways, the TFPI market shows   strong potential for innovation.

DelveInsight’s report – TFPI Market Size, Target Population, Competitive Landscape and Market Forecast – 2034 – provides:
– Comprehensive epidemiological analysis across major markets
– Current and emerging therapeutic strategies, including recombinant proteins, monoclonal antibodies, and fusion molecules
– Pipeline landscape with novel candidates and ongoing clinical trials
– Market dynamics – key drivers, barriers, and opportunities shaping TFPI adoption
– Competitive landscape highlighting leading pharmaceutical and biotechnology innovators

Key Players in the TFPI Companies space include Bayer, Novo Nordisk, Sanofi, Pfizer, Bristol Myers Squibb, CSL , Shire, Alnylam Pharmaceuticals, and others.

With ongoing R&D, growing patient populations, and global initiatives to improve thrombotic care, the TFPI market is poised for significant growth and innovation through 2034.

Access the full report here.”

TFPI

Stay updated with Hemostasis Today.

Alnylam Pharmaceuticals Bayer Bristol Myers Squibb CSL DelveInsight Business Research LLP Global Growth Drivers Health Hematology Hemostasis Hemostasis Today Kanishk Kumar Medicine Novel Anticoagulants Novo Nordisk Pfizer Sanofi Shire TFPI TFPI Companies TFPI Market thrombosis Tissue Factor Pathway Inhibitors
NewsFeed